Reference |
---|
Khan M, Harms J, Liu Y, Eickhoff J, Tan J, Hu T, et al. Brucella suppress STING expression via miR-24 to enhance infection. PLoS Pathog. 2020;16:e1009020 pubmed publisher
|
Piersma S, Poursine Laurent J, Yang L, Barber G, Parikh B, Yokoyama W. Virus infection is controlled by hematopoietic and stromal cell sensing of murine cytomegalovirus through STING. elife. 2020;9: pubmed publisher
|
Sousa J, Cá B, Maceiras A, Simões Costa L, Fonseca K, Fernandes A, et al. Mycobacterium tuberculosis associated with severe tuberculosis evades cytosolic surveillance systems and modulates IL-1β production. Nat Commun. 2020;11:1949 pubmed publisher
|
Reimer E, Stempel M, Chan B, Bley H, Brinkmann M. Protein tyrosine phosphatase 1B is involved in efficient type I interferon secretion upon viral infection. J Cell Sci. 2020;134: pubmed publisher
|
Karki R, Lee E, Sharma B, Banoth B, Kanneganti T. IRF8 Regulates Gram-Negative Bacteria-Mediated NLRP3 Inflammasome Activation and Cell Death. J Immunol. 2020;204:2514-2522 pubmed publisher
|
Fritzlar S, Aktepe T, Chao Y, Kenney N, McAllaster M, Wilen C, et al. Mouse Norovirus Infection Arrests Host Cell Translation Uncoupled from the Stress Granule-PKR-eIF2α Axis. MBio. 2019;10: pubmed publisher
|
Yang S, Harding A, Sweeney C, Miao D, Swan G, Zhou C, et al. Control of antiviral innate immune response by protein geranylgeranylation. Sci Adv. 2019;5:eaav7999 pubmed publisher
|
Kwon H, Patra M, Shin H, Gui X, Achek A, Panneerselvam S, et al. A cell-penetrating peptide blocks Toll-like receptor-mediated downstream signaling and ameliorates autoimmune and inflammatory diseases in mice. Exp Mol Med. 2019;51:50 pubmed publisher
|
Srikanth S, Woo J, Wu B, El Sherbiny Y, Leung J, Chupradit K, et al. The Ca2+ sensor STIM1 regulates the type I interferon response by retaining the signaling adaptor STING at the endoplasmic reticulum. Nat Immunol. 2019;20:152-162 pubmed publisher
|
Tong Y, Zhou L, Yang L, Guo P, Cao Y, Qin F, et al. Concomitant type I IFN and M-CSF signaling reprograms monocyte differentiation and drives pro-tumoral arginase production. EBioMedicine. 2019;39:132-144 pubmed publisher
|
Cheng W, He X, Jia H, Chen G, Jin Q, Long Z, et al. The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus. Front Immunol. 2018;9:1297 pubmed publisher
|
Stavrou S, Aguilera A, Blouch K, Ross S. DDX41 Recognizes RNA/DNA Retroviral Reverse Transcripts and Is Critical for In Vivo Control of Murine Leukemia Virus Infection. MBio. 2018;9: pubmed publisher
|
Zhou P, Ding X, Wan X, Liu L, Yuan X, Zhang W, et al. MLL5 suppresses antiviral innate immune response by facilitating STUB1-mediated RIG-I degradation. Nat Commun. 2018;9:1243 pubmed publisher
|
Oldenburg R, Mayau V, Prandi J, Arbués A, Astarie Dequeker C, Guilhot C, et al. Mycobacterial Phenolic Glycolipids Selectively Disable TRIF-Dependent TLR4 Signaling in Macrophages. Front Immunol. 2018;9:2 pubmed publisher
|
Yan S, Shen H, Lian Q, Jin W, Zhang R, Lin X, et al. Deficiency of the AIM2-ASC Signal Uncovers the STING-Driven Overreactive Response of Type I IFN and Reciprocal Depression of Protective IFN-γ Immunity in Mycobacterial Infection. J Immunol. 2018;200:1016-1026 pubmed publisher
|
Yoshida A, Kawabata R, Honda T, Sakai K, Ami Y, Sakaguchi T, et al. A Single Amino Acid Substitution within the Paramyxovirus Sendai Virus Nucleoprotein Is a Critical Determinant for Production of Interferon-Beta-Inducing Copyback-Type Defective Interfering Genomes. J Virol. 2018;92: pubmed publisher
|
Nanda S, López Pelaéz M, Arthur J, Marchesi F, Cohen P. Suppression of IRAK1 or IRAK4 Catalytic Activity, but Not Type 1 IFN Signaling, Prevents Lupus Nephritis in Mice Expressing a Ubiquitin Binding-Defective Mutant of ABIN1. J Immunol. 2016;197:4266-4273 pubmed
|
Wu Y, Ren D, Chen G. Siglec-E Negatively Regulates the Activation of TLR4 by Controlling Its Endocytosis. J Immunol. 2016;197:3336-3347 pubmed
|
Jiang H, Shi H, Sun M, Wang Y, Meng Q, Guo P, et al. PFKFB3-Driven Macrophage Glycolytic Metabolism Is a Crucial Component of Innate Antiviral Defense. J Immunol. 2016;197:2880-90 pubmed publisher
|
Shepardson K, Larson K, Morton R, Prigge J, Schmidt E, Huber V, et al. Differential Type I Interferon Signaling Is a Master Regulator of Susceptibility to Postinfluenza Bacterial Superinfection. MBio. 2016;7: pubmed publisher
|
Ferri F, Parcelier A, Petit V, Gallouet A, Lewandowski D, Dalloz M, et al. TRIM33 switches off Ifnb1 gene transcription during the late phase of macrophage activation. Nat Commun. 2015;6:8900 pubmed publisher
|
Lv M, Wu W, Zhang Y, Zhu M. Herpes virus entry mediator licenses Listeria infection induced immunopathology through control of type I interferon. Sci Rep. 2015;5:12954 pubmed publisher
|
Zhu M, Fang T, Li S, Meng K, Guo D. Bipartite Nuclear Localization Signal Controls Nuclear Import and DNA-Binding Activity of IFN Regulatory Factor 3. J Immunol. 2015;195:289-97 pubmed publisher
|
Shah S, Bohsali A, Ahlbrand S, Srinivasan L, Rathinam V, Vogel S, et al. Cutting edge: Mycobacterium tuberculosis but not nonvirulent mycobacteria inhibits IFN-? and AIM2 inflammasome-dependent IL-1? production via its ESX-1 secretion system. J Immunol. 2013;191:3514-8 pubmed publisher
|
Wang S, Wang K, Li J, Zheng C. Herpes simplex virus 1 ubiquitin-specific protease UL36 inhibits beta interferon production by deubiquitinating TRAF3. J Virol. 2013;87:11851-60 pubmed publisher
|